BMI and Differential Epithelial and Stromal ER/PR Expression within Type I and Type II Endometrial Carcinoma

被引：0
|
作者：
Peevey, Joseph [1 ]
Maniar, Kruti P. [1 ]
Kim, Ji-Yong Julie [1 ]
机构：
[1] Northwestern Mem Hosp, Chicago, IL USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1219
引用
收藏
页码：304A / 304A
页数：1
相关论文
共 50 条
  • [21] Differential Expression of Phosphorylated γH2AX in the Stroma of Type I and II Endometrial Carcinomas
    Brustmann, Hermann
    MODERN PATHOLOGY, 2015, 28 : 277A - 277A
  • [22] A comparison of tumor size at diagnosis and disease recurrence in type I and type II endometrial carcinoma
    Whicker, M. E.
    McGregor, K. A.
    Black, J. D.
    Passarelli, R.
    Albright, B.
    Gysler, S.
    Altwerger, G.
    Menderes, G.
    Schwartz, P. E.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 132 - 132
  • [23] The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma
    Chen, Jingya
    Fan, Weimin
    Gu, Hailei
    Wang, Yaohui
    Liu, Yuting
    Chen, Xiao
    Ren, Shuai
    Wang, Zhongqiu
    ACTA RADIOLOGICA, 2021, 62 (07) : 959 - 965
  • [24] Mitochondrial DNA mutations within the progression model of type I endometrial carcinoma
    Gadaleta, M. N.
    Guerra, F.
    Kurelac, I.
    Cormio, A.
    Zuntini, R.
    Amato, L.
    Ceccarelli, C.
    Santini, D.
    Cormio, G.
    Fracasso, F.
    Selvaggi, L.
    Resta, L.
    Attimonelli, M.
    Gasparre, G.
    FEBS JOURNAL, 2011, 278 : 207 - 207
  • [25] Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors
    Iyengar, TD
    Ng, SW
    Lau, CC
    Welch, WR
    Bell, DA
    Berkowitz, RS
    Mok, SC
    ONCOGENE, 1999, 18 (01) : 257 - 262
  • [26] Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors
    Tara D Iyengar
    Shu-wing Ng
    Ching C Lau
    William R Welch
    Debra A Bell
    Ross S Berkowitz
    Samuel C Mok
    Oncogene, 1999, 18 : 257 - 262
  • [27] TYPE I VS. II ENDOMETRIAL CANCER: DIFFERENTIAL IMPACT OF COMORBIDITY
    Noer, M.
    Antonsen, S. L.
    Ottesen, B.
    Christensen, I. J.
    Hogdall, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1168 - 1168
  • [28] TYPE I VS. II ENDOMETRIAL CANCER: DIFFERENTIAL IMPACT OF COMORBIDITY
    Noer, M.
    Antonsen, S. L.
    Ottesen, B.
    Christensen, I. J.
    Hogdall, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 442 - 442
  • [29] Factors associated with Type I and Type II endometrial cancer
    Felix, Ashley S.
    Weissfeld, Joel L.
    Stone, Roslyn A.
    Bowser, Robert
    Chivukula, Mamatha
    Edwards, Robert P.
    Linkov, Faina
    CANCER CAUSES & CONTROL, 2010, 21 (11) : 1851 - 1856
  • [30] Factors associated with Type I and Type II endometrial cancer
    Ashley S. Felix
    Joel L. Weissfeld
    Roslyn A. Stone
    Robert Bowser
    Mamatha Chivukula
    Robert P. Edwards
    Faina Linkov
    Cancer Causes & Control, 2010, 21 : 1851 - 1856
12345